Muscimol-like discriminative stimulus effects of GABA agonists in rats

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 319-326

  Jones, Hendrée E ^a   Balster, Robert L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diazepam; Drug discrimination; GABA (gamma aminobutyric acid); GABA transaminase inhibitors; Muscimol; Rats; THIP; Valproic acid; Vigabatrin

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; DIAZEPAM; GABOXADOL; MUSCIMOL; PROGABIDE; TIAGABINE; VALPROIC ACID; VIGABATRIN;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; MALE; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; REINFORCEMENT;

4-AMINOBUTYRATE TRANSAMINASE; ANIMALS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GABA AGONISTS; GABA ANTAGONISTS; MALE; MUSCIMOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032004908     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00413-9     Document Type: Article

References (43)

1. B agonist baclofen. Soc. Neurosci. Abstr. 8:1991;465.
2. Ator N. A., Griffiths R. R. Lorazepam and pentobarbital drug discrimination in baboons. Cross drug generalization tests and interaction with Ro-15-1788 J. Pharmacol. Exp. Ther. 226:1983;776-782.
3. Ator N. A., Griffiths R. R. Discriminative stimulus effects of atypical anxiolytics in baboons and rats. J. Pharmacol. Exp. Ther. 237:1983;393-403.
4. Ator N. A., Griffiths R. R. Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam or triazolam. Psychopharmacology (Berlin). 98:1989;20-30.
5. Barry H. III Classification of drugs according to their discriminable effects in rats. Fed. Proc. 33:1974;1814-1824.
6. Bergmann K. J. Progabide. A new GABA-mimetic agent in clinical use Clin. Neuropharmacol. 8:1985;13-26.
7. Braestrup C., Nielsen E. B., Sonnewald U., Knutsen L. J. S., Anderson K. E., Jansen J. A., Frederiksen K., Andersen P. H., Mortensen A., Suzdak P. D. R)-N-[4,4-Bis(3-methyl-2-thienyl)but-3-en-l-yl] nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier. J. Neurochem. 54:1990;639-647.
8. Chapman A., Keanse P. E., Meldrum B. S., Simiand J., Vernieres J. C. Mechanisms of anitconvulsant action of valproate. Prog. Neurobiol. 19:1982;315-359.
9. Colpaert F. C., Desmedt L. K. C., Janssen P. A. J. Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs. Relation to some intrinsic and anticonvulsant effects Eur. J. Pharmacol. 37:1976;113-123.
10. 35S]butylbicyclophosphorothionate binding to rat cerebral cortex. Eur. J. Pharmacol. 1:1990;497-503.
11. Emmett-Ogelsby M. W. Tolerance to the discriminative stimulus effects of ethanol. Behav. Pharmacol. 1:1990;497-503.
12. Gram L. Tiagabine. A novel drug with a GABAergic mechanism of action Epilepsia. 35:1994;s85-s87.
13. Grant S. M., Heel R. C. Vigabatrin. A review of its pharmodynamic and pharmokinetic potential in epilepsy and disorders of motor control Drugs. 41:1991;889-926.
14. Grech D. M., Balster R. L. Pentobarbital-like discriminative stimulus effects of direct GABA agonists in rats. Psychopharmacology (Berlin). 110:1993;285-301.
15. Grech D. M., Balster R. L. Discriminative stimulus effects of presynaptic GABA agonists in pentobarbital-trained rats. Pharmacol. Biochem. Behav. 47:1994;5-11.
16. Grech D. M., Balster R. L. The discriminative stimulus effects of muscimol in rats. Psychopharmacology (Berlin). 129:1997;339-347.
17. Haefely, W.: Benzodiazepine receptor and ligands: Structural and functional differences. In: Hindmarch, I.; Beaumont, G.; Brandon, S.; Leonard, B. E., eds. Benzodiazepines: Current concepts. New York: J. Wiley & Sons Ltd; 1990:1-18.
18. Hammond E. J., Wilder B. J. Gamma-vinyl GABA. Gen. Pharmacol. 16:1985;441-447.
19. A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology. 79:1993;781-788.
20. Hasan M. M., Hasan Z. A., al-Hader A. F., Takrouri M. S. The anticonvulsant effects of propofol, diazepam and thiopental against picrotoxin-induced seizure in the rat. Middle East J. Anesthesiol. 12:1993;113-121.
21. Herling S., Valentino R. J., Winger G. D. Discriminative stimulus effects of pentobarbital in pigeons. Psychopharmacology (Berlin). 71:1980;21-28.
22. Jung M. J., Lippert B., Metcalf B. W., Bohlen P., Schechter P. J. Gamma-vinyl GABA (4-amino-hex-enoic acid), a new selective irreversible inhibitor of GABA-T. Effects on brain GABA metabolism in mice J. Neurochem. 29:1977;797-802.
23. Kelly K. M., Gross R. A., Macdonald R. L. Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci. Lett. 116:1990;233-238.
24. Kline F. S., Young A. M. Differential modification of pentobarbital stimulus control by d-amphetamine and ethanol. Pharmacol. Biochem. Behav. 24:1986;1305-1313.
25. A receptor agonists, partial agonists and antagonists. Design and theraputic prospects. J. Med. Chem. 37:1994;2489-2505.
26. Lal H., Shearman G. T., Fielding S., Dunn R., Kruse H., Theurer K. Evidence that GABA mechanisms mediate the anxiolytic action of benzodiazepines. A study with valproic acid Neuropharmacology. 19:1980;785-789.
27. Lloyd K. G., Arbilla S., Beaumont K., Briley M., De Montis G., Scatton B., Langer S. Z., Bartholini G. Gamma aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor. J. Pharmacol. Exp. Ther. 220:1982;672-677.
28. Mantz J., Lecharny J. B., Laudenbach V., Henzel D., Peytavin G., Desmonts J. M. Anesthetics affect the uptake but not the depolarization evoked release of GABA in rat striatal synaptosomes. Anesthesiology. 82:1995;502-511.
29. McLean M. J., Macdonald R. L. Sodium valproate, but not ethosuximide, produces use-voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 237:1986;1001-1011.
30. Metcalf B. W. Inhibitors of GABA metabolism. Biochem. Pharmacol. 28:1979;1705-1712.
31. Nielsen E. B., Suzdak P. D., Anderson K. E., Knutsen L. J., Sonnewald V., Braestrup C. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur. J. Pharmacol. 196:1991;257-266.
32. Palfreyman M. G., Schechter P. J., Buckett W. R., Tell G., Koch-Weser J. The pharmacology of GABA transaminase inhibitors. Biochem. Pharmacol. 30:1981;817-824.
33. Prince R. J., Simmonds M. A. Temperature and anion dependence of allosteric interaction of the gamma-aminobutyric acid-benzodiazepine receptors. Biochem. Pharmacol. 44:1992;1297-1302.
34. Rauch J., Stolerman I. P. Midazolam cue in rats. Effects of drugs acting on GABA and 5-hydroxytryptamine systems, anticonvulsants and sedatives J. Psychopharmacol. 2:1987;71-80.
35. Rowan A. J., Ahmann P., Wannamaker B., Schachter S., Rask C., Uthman B. Safety and efficacy of three dose levels of tiagabine HCL vs. placebo as adjunctive treatment for complex partial seizures. Epilepsia. 34(Suppl. 2):1993;157.
36. Sanger D. J. Discriminative stimulus properties of anxiolytic and sedative drugs; Pharmacological specificity. Colpaert F. C., Balster R. L. Transduction mechanisms of drug stimuli. 1988;73-84 Springer Verlag, Berlin.
37. A receptors. Influence on receptor subunits J. Pharmacol. Exp. Ther. 274:1995;353-360.
38. Shelton K. L., Balster R. L. Ethanol drug discrimination in rats. Substitution with GABA agonists and NMDA antagonists Behav. Pharmacol. 5:1994;441-450.
39. Spealman R. D. Discriminative-stimulus effects of midazolam in squirrel monkeys. Comparison with other drugs and antagonism by Ro 15-1788 J. Pharmacol. Exp. Ther. 235:1985;456-462.
40. Tallarida R. J., Murray R. B. Manual of pharmacological calculations with computer programs. 2:1986;Springer Verlag, New York.
41. Tamminga C. A., Thaker G. K. GABAmimetic drugs in hyperkinetic involuntary movement disorders and their effects on mental status. Drug Dev. Res. 21:1990;227-233.
42. Worms P., Depoortere H., Durand A., Morselli P. L., Lloyd K. G., Bartholin G. Gamma-aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacology. J. Pharmacol. Exp. Ther. 220:1982;656-668.
43. Van der Laan J. W., de Beer T., Bruinuels J. Di-n-propylacetate and GABA degradation, preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase. J. Neurochem. 32:1979;1769-1780.